Update on neuroblastoma Review


Authors: Newman, E. A.; Abdessalam, S.; Aldrink, J. H.; Austin, M.; Heaton, T. E.; Bruny, J.; Ehrlich, P.; Dasgupta, R.; Baertschiger, R. M.; Lautz, T. B.; Rhee, D. S.; Langham, M. R. Jr; Malek, M. M.; Meyers, R. L.; Nathan, J. D.; Weil, B. R.; Polites, S.; Madonna, M. B.; on behalf of the APSA Cancer committee
Review Title: Update on neuroblastoma
Abstract: Neuroblastoma is an embryonic cancer arising from neural crest stem cells. This cancer is the most common malignancy in infants and the most common extracranial solid tumor in children. The clinical course may be highly variable with the possibility of spontaneous regression in the youngest patients and increased risk of aggressive disease in older children. Clinical heterogeneity is a consequence of the diverse biologic characteristics that determine patient risk and survival. This review will focus on current progress in neuroblastoma staging, risk stratification, and treatment strategies based on advancing knowledge in tumor biology and genetic characterization. Type of study: Review article. Level of evidence: Level II. © 2018 Elsevier Inc.
Keywords: solid tumor; treatment; oncology; neuroblastoma; surgery; cancer
Journal Title: Journal of Pediatric Surgery
Volume: 54
Issue: 3
ISSN: 0022-3468
Publisher: W.B. Saunders Co-Elsevier Inc.  
Date Published: 2019-03-01
Start Page: 383
End Page: 389
Language: English
DOI: 10.1016/j.jpedsurg.2018.09.004
PUBMED: 30305231
PROVIDER: scopus
DOI/URL:
Notes: Review -- Export Date: 1 March 2019 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Todd Erin Heaton
    44 Heaton
Related MSK Work